Dr. Adan Rios, associate professor of internal medicine, made a pair of special appearances on the world stage again last month to discuss the challenges with the development of a preventative HIV vaccine.
Addressing a critical issue for people with a genetic disorder called tuberous sclerosis complex (TSC), doctors at McGovern Medical School reported that a skin cream containing rapamycin significantly reduced the disfiguring facial tumors affecting more than 90 percent of people with the condition.
In a landmark study, researchers found that patients treated with paramedic oxygen delivery using a newer, more flexible laryngeal breathing tube may have a greater survival rate after sudden cardiac arrest than the traditional intubation breathing tube.
A scientific quest that started in 1905 has been achieved by scientists at McGovern Medical School, who reported that they are the first to grow a long-lasting tissue culture of the bacterium responsible for syphilis. Findings appeared in the journal mBio.
The Tiny Tot Clinic for Neurodevelopmental and Behavioral Health at UT Physicians, the clinical practice of McGovern Medical School, is now one of only seven programs nationwide to be invited to take part in a new initiative by the Cerebral Palsy Foundation designed to improve diagnosis and intervention results.
When scientists at McGovern Medical School applied a chemical found in soybeans to a non-steroidal anti-inflammatory drug (NSAID), they increased its anticancer properties and reduced its side effects. Findings of the preclinical study of phosphatidylcholine, also called lecithin, appear in the journal Oncology Letters.
Doctors could be a step closer to finding the most effective way to treat cancer with a double whammy of a virus combined with boosting the natural immune system, according to a pioneering study by researchers at The University of Texas Health Science Center at Houston (UTHealth) and The Ohio State University.
A study led by a neurologist from McGovern Medical School showed that a computed tomography (CT scan) could be sufficient for determining thrombectomy treatment in stroke.
Professors from several departments at McGovern Medical School shared research presentations with thousands of scientists in biophysics at the 62nd Annual Meeting of the Biophysical Society (BPS) earlier this year.
With the help of gene editing and the African clawed frog, researchers in the laboratory of Dr. Rachel K. Miller in the Department of Pediatrics at McGovern Medical School have found a cost-effective model for studying the genetics of developmental kidney diseases.